Proposed sale of 22,500 common shares

Morgan Stanley Smith Barney LLC filed a Form 144 notice concerning 22,500 shares of common stock of EVMN proposed for sale following an Exercise of Stock Options dated 05/28/2026.

Rhea-AI Filing Summary

Morgan Stanley Smith Barney LLC filed a Form 144 notice concerning 22,500 shares of common stock of EVMN proposed for sale following an Exercise of Stock Options dated 05/28/2026. The filing also lists a Pre-IPO Purchase of 3,175 shares dated 04/26/2023.

Insights

Equity Capital Markets Analyst

Form 144 lists a proposed resale of 22,500 EVMN common shares following option exercise.

The notice documents a sale method tied to an Exercise of Stock Options on 05/28/2026 for 22,500 shares. The record also shows a separate Pre-IPO Purchase of 3,175 shares on 04/26/2023.

These entries are routine broker-handled resale notices and do not, by themselves, report settlement details, proceeds recipients, or trading venue in the provided excerpt. Subsequent filings may disclose completion or price information.

Key Figures

Proposed shares to sell: 22,500 shares Pre-IPO shares purchased: 3,175 shares Broker/filing agent: Morgan Stanley Smith Barney LLC

3 metrics

Proposed shares to sell 22,500 shares Exercise of Stock Options on <date>05/28/2026</date>

Pre-IPO shares purchased 3,175 shares Pre-IPO Purchase on <date>04/26/2023</date>

Broker/filing agent Morgan Stanley Smith Barney LLC Listed as filing broker/agent

Key Terms

Form 144, Exercise of Stock Options, Pre-IPO Purchase

3 terms

Form 144 regulatory

"filed a Form 144 notice concerning 22,500 shares"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Exercise of Stock Options financial

"following an Exercise of Stock Options dated 05/28/2026"

Pre-IPO Purchase financial

"lists a Pre-IPO Purchase of 3,175 shares dated 04/26/2023"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 for EVMN report?

The Form 144 reports a proposed resale of 22,500 shares following an Exercise of Stock Options dated 05/28/2026. It also lists a separate Pre-IPO Purchase of 3,175 shares dated 04/26/2023.

Who filed the Form 144 for EVMN shares?

The filing lists Morgan Stanley Smith Barney LLC Executive Financial Services as the broker/filing agent associated with the proposed resale of 22,500 shares on 05/28/2026.

Does the Form 144 state how proceeds will be used?

The excerpt does not include any use of proceeds language. The filing records the method as an Exercise of Stock Options and lists share counts and dates but does not state proceeds allocation.

Are the listed share counts the only holdings disclosed?

The excerpt shows two specific entries: 22,500 shares (option exercise) and 3,175 shares (pre-IPO purchase). It does not present a broader beneficial ownership total or post-transaction holdings in the provided text.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/28/2026 - 04:35 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001757072
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Evommune, Inc.
SEC File Number	001-42938
Address of Issuer	1891 Page Mill Road Palo Alto CALIFORNIA 94304
Phone	925-247-4481
Name of Person for Whose Account the Securities are To Be Sold	KYLE CARVER
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	25675	599254.50	36018372	05/28/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/28/2026	Exercise of Stock Options	Issuer			22500	05/28/2026	Cash
Common	04/26/2023	Pre-IPO Purchase of Common Shares	Issuer			3175	04/26/2023	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	The securities to be sold were and will be received upon the exercise of stock options over the next three months. The dates of acquisition and payment were and will be the dates of exercise/sale.
Date of Notice	05/28/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	02/26/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Kyle Carver
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)